Roche Diagnostics and Sulaiman Al-Habib sign deal

At Arab Health Exhibition & Congress, Roche Diagnostics and Dr. Sulaiman Al-Habib Medical Group came together to sign the Middle East’s largest private health care deal
It was signed at the Roche Diagnostics stand located in Sheikh Maktoum Hall.
The groundbreaking deal will see Roche Diagnostics Total Lab Automization (TLA) solutions installed in four leading hospitals within Riyadh.
Furthering the advancement of modern health care Roche Diagnostics TLA solutions provide an exceptionally high level of quality and continuity in the laboratory.
This means reduced manual intervention during the diagnostic process, in turn this significantly minimizing the element of human error occurring.
The official signature ceremony was attended by Roche Diagnostics President EMEA-LATAM, Dr. Michael Heuer and Dr. Ibrahim Alomar, vice president for laboratories affairs at Dr. Sulaiman Al-Habib Medical Group.
Commenting at the ceremony, Roche Diagnostics President EMEA-LATAM, Michael Heuer said: “This ground breaking deal embodies our commitment to providing innovative health care solutions to the private and public sector as well as being a testimony to the importance the KSA market holds for us. What better way to evidence this than through joining forces with one of the largest providers of comprehensive health care services in the region; Dr. Sulaiman Al Habib Medical Group.”
Dr. Ibrahim Alomar, vice president for Laboratories Affairs at Dr. Sulaiman Al Habib Medical Group, added: “We are confident that Roche Diagnostics’ broad range of innovative diagnostic tests and systems will play a pivotal role in the advancement of integrated health care solutions offered at Dr. Sulaiman Al Habib Medical Group and cover the early detection, targeted screening, evaluation and monitoring of disease.”
Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring.